These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26183331)

  • 1. Formulation and nebulization of fluticasone propionate-loaded lipid nanocarriers.
    Umerska A; Mouzouvi CR; Bigot A; Saulnier P
    Int J Pharm; 2015 Sep; 493(1-2):224-32. PubMed ID: 26183331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation, Optimization and
    Tasharoie S; Ostad SN; Amini M; Sabourian R; Gilani K
    Recent Adv Drug Deliv Formul; 2024; 18(1):61-76. PubMed ID: 38362679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-insertion into Lipid NanoCapsules (LNCs): From experimental aspects to mechanisms.
    Perrier T; Saulnier P; Fouchet F; Lautram N; Benoît JP
    Int J Pharm; 2010 Aug; 396(1-2):204-9. PubMed ID: 20600733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid nanocapsules: ready-to-use nanovectors for the aerosol delivery of paclitaxel.
    Hureaux J; Lagarce F; Gagnadoux F; Vecellio L; Clavreul A; Roger E; Kempf M; Racineux JL; Diot P; Benoit JP; Urban T
    Eur J Pharm Biopharm; 2009 Oct; 73(2):239-46. PubMed ID: 19560538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of immuno-nanocarriers targeting the cancer stem cell marker AC133.
    Bourseau-Guilmain E; Béjaud J; Griveau A; Lautram N; Hindré F; Weyland M; Benoit JP; Garcion E
    Int J Pharm; 2012 Feb; 423(1):93-101. PubMed ID: 21683129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability.
    Paillard A; Hindré F; Vignes-Colombeix C; Benoit JP; Garcion E
    Biomaterials; 2010 Oct; 31(29):7542-54. PubMed ID: 20630585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial action of lipid nanocapsules containing fatty acids or monoglycerides as co-surfactants.
    Umerska A; Cassisa V; Matougui N; Joly-Guillou ML; Eveillard M; Saulnier P
    Eur J Pharm Biopharm; 2016 Nov; 108():100-110. PubMed ID: 27597268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface active properties of lipid nanocapsules.
    Mouzouvi CRA; Umerska A; Bigot AK; Saulnier P
    PLoS One; 2017; 12(8):e0179211. PubMed ID: 28796777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inter-nanocarrier and nanocarrier-to-cell transfer assays demonstrate the risk of an immediate unloading of dye from labeled lipid nanocapsules.
    Simonsson C; Bastiat G; Pitorre M; Klymchenko AS; Béjaud J; Mély Y; Benoit JP
    Eur J Pharm Biopharm; 2016 Jan; 98():47-56. PubMed ID: 26522878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and characterization of lecithin stabilized glibenclamide nanocrystals for enhanced solubility and drug delivery.
    Kumar BS; Saraswathi R; Kumar KV; Jha SK; Venkates DP; Dhanaraj SA
    Drug Deliv; 2014 May; 21(3):173-84. PubMed ID: 24102185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and Optimization Lipid Nanocapsules to Enhance the Antitumor Efficacy of Cisplatin in Hepatocellular Carcinoma HepG2 Cells.
    Zhai Q; Li H; Song Y; Wu R; Tang C; Ma X; Liu Z; Peng J; Zhang J; Tang Z
    AAPS PharmSciTech; 2018 Jul; 19(5):2048-2057. PubMed ID: 29679292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inner ear biocompatibility of lipid nanocapsules after round window membrane application.
    Zhang Y; Zhang W; Löbler M; Schmitz KP; Saulnier P; Perrier T; Pyykkö I; Zou J
    Int J Pharm; 2011 Feb; 404(1-2):211-9. PubMed ID: 21075187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of a 12-week therapy with a new formulation of fluticasone propionate at doses of 125 and 250 μg administered through a new generation cyclohaler twice daily, in comparison to fluticasone propionate 500 μg dry powder inhaler twice daily in patients with moderate asthma.
    Kupryś-Lipińska I; Tworek D; Vanderbist F; Bocheńska-Marciniak M; Kuna P
    Pneumonol Alergol Pol; 2013; 81(6):527-36. PubMed ID: 24142782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro drug release mechanism from lipid nanocapsules (LNC).
    Abdel-Mottaleb MM; Neumann D; Lamprecht A
    Int J Pharm; 2010 May; 390(2):208-13. PubMed ID: 20149853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma.
    Huynh NT; Passirani C; Allard-Vannier E; Lemaire L; Roux J; Garcion E; Vessieres A; Benoit JP
    Int J Pharm; 2012 Feb; 423(1):55-62. PubMed ID: 21536115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAMAM dendrimers as aerosol drug nanocarriers for pulmonary delivery via nebulization.
    Nasr M; Najlah M; D'Emanuele A; Elhissi A
    Int J Pharm; 2014 Jan; 461(1-2):242-50. PubMed ID: 24275446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb Pro: formulation aspects and nanoparticle stability to nebulization.
    Beck-Broichsitter M; Kleimann P; Gessler T; Seeger W; Kissel T; Schmehl T
    Int J Pharm; 2012 Jan; 422(1-2):398-408. PubMed ID: 22001839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dry powder formulations for inhalation of fluticasone propionate and salmeterol xinafoate microcrystals.
    Murnane D; Martin GP; Marriott C
    J Pharm Sci; 2009 Feb; 98(2):503-15. PubMed ID: 18506819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
    Singh DJ; Jain RR; Soni PS; Abdul S; Darshana H; Gaikwad RV; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):254-67. PubMed ID: 25517187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.
    Le VN; Robins E; Flament MP
    Eur J Pharm Biopharm; 2012 Apr; 80(3):596-603. PubMed ID: 22198291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.